Dopamine and serotonin genetic risk scores predicting substance and nicotine use in attention deficit/hyperactivity disorder

Addiction Biology

Volumn 21, Issue 4, 2016, Pages 915-923

  Groenman, Annabeth P ^a,b   Greven, Corina U ^b,c,d   van Donkelaar, Marjolein M J ^b   Schellekens, Arnt ^b,e   van Hulzen, Kimm J E ^b   Rommelse, Nanda ^b,d   Hartman, Catharina A ^f   Hoekstra, Pieter J ^f   Luman, Marjolein ^a   Franke, Barbara ^b   Faraone, Stephen V ^g,h   Oosterlaan, Jaap ^a   Buitelaar, Jan K ^b,d  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d Child and Adolescent Psychiatry University Centre   (Netherlands)

^e Nijmegen Institute for Science Practitioners in Addiction (NISPA)   (Netherlands)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^h UNIVERSITY OF BERGEN   (Norway)

Author keywords

ADHD; adolescence; genetic risk scores; nicotine use; substance use

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN 3B RECEPTOR; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE 2;

5 HTT GENE; ADOLESCENT; AGE; ALCOHOL CONSUMPTION; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; COMORBIDITY; COMT GENE; CONTROLLED STUDY; DAT1 GENE; DBH GENE; DRD2 GENE; DRD3 GENE; DRD4 GENE; FEMALE; GENE; GENETIC RISK; HTR1A GENE; HTR1B GENE; HTR2A GENE; HTR3B GENE; HUMAN; MALE; NEUROTRANSMISSION; PRIORITY JOURNAL; QUESTIONNAIRE; SEMI STRUCTURED INTERVIEW; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; TPH1 GENE; TPH2 GENE;

EID: 84975063309     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/adb.12230     Document Type: Article

References (51)

1. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders [DSM-IV-TR], Washington, DC: American Psychiatric Association.
2. Bari A, Robbins TW (2013) Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol 108:44–79.
3. Bobzean SA, Denobrega AK, Perrotti LI (2014) Sex differences in the neurobiology of drug addiction. Exp Neurol 259:64–74.
4. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, Aneey R, Franke B, Gill M, Ebstein R (2006) The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 11:934–953.
5. Carpentier PJ, Arias Vasquez A, Hoogman M, Onnink M, Kan CC, Kooij JJ, Makkinje R, Iskandar S, Kiemeney LA, de Jong CA, Franke B, Buitelaar JK (2013) Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: a pilot study of six candidate genes. Eur Neuropsychopharmacol 23:448–457.
6. Charach A, Yeung E, Climans T, Lillie E (2011) Childhood attention-deficit/hyperactivity disorder and future substance use disorders: comparative meta-analyses. J Am Acad Child Adolesc Psychiatry 50:9–21.
7. Cortese S, Kelly C, Chabernaud C, Proal E, Di Martino A, Milham MP, Castellanos FX (2012) Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies. Am J Psychiatry 169:1038–1055.
8. del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW (2011) The roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorder. Biol Psychiatry 69:e145–e157.
9. Dalley JW, Roiser JP (2012) Dopamine, serotonin and impulsivity. Neuroscience 215:42–58.
10. Davis C, Loxton NJ, Levitan RD, Kaplan AS, Carter JC, Kennedy JL (2013) ‘Food addiction’ and its association with a dopaminergic multilocus genetic profile. Physiol Behav 118:63–69.
11. Di Matteo V, Pierucci M, Benigno A, Esposito E, Crescimanno G, Di Giovanni G (2010) Critical role of nitric oxide on nicotine-induced hyperactivation of dopaminergic nigrostriatal system: electrophysiological and neurochemical evidence in rats. CNS Neurosci Ther 16:127–136.
12. Eagle DM, Lehmann O, Theobald DE, Pena Y, Zakaria R, Ghosh R, Dalley JW, Robbins TW (2009) Serotonin depletion impairs waiting but not stop-signal reaction time in rats: implications for theories of the role of 5-HT in behavioral inhibition. Neuropsychopharmacology 34:1311–1321.
13. Franke B, Neale BM, Faraone SV (2009) Genome-wide association studies in ADHD. Hum Genet 126:13–50.
14. Garnock-Jones KP, Keating GM (2010) Spotlight on atomoxetine in attention-deficit hyperactivity disorder in children and adolescents. CNS Drugs 24:85–88.
15. Groenman AP, Oosterlaan J, Rommelse N, Franke B, Roeyers H, Oades RD, Sergeant JA, Buitelaar JK, Faraone SV (2013) Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study. Addiction 108:1503–1511.
16. Groenman AP, Oosterlaan J, Greven CU, Vuijk PJ, Rommelse N, Franke B, Hartman CA, Hoekstra PJ, Sergeant J, Faraone SV, Buitelaar J (2014) Neurocognitive predictors of substance use disorders and nicotine dependence in ADHD probands, their unaffected siblings, and controls: a 4-year prospective follow-up. J Child Psychol Psychiatry doi: 10.1111/jcpp.12315. [Epub ahead of print].
17. Guo G, Wilhelmsen K, Hamilton N (2007) Gene-lifecourse interaction for alcohol consumption in adolescence and young adulthood: five monoamine genes. Am J Med Genet B Neuropsychiatr Genet 144b:417–423.
18. Hoogman M, Aarts E, Zwiers M, Slaats-Willemse D, Naber M, Onnink M, Cools R, Kan C, Buitelaar J, Franke B (2011) Nitric oxide synthase genotype modulation of impulsivity and ventral striatal activity in adult ADHD patients and healthy comparison subjects. Am J Psychiatry 168:1099–1106.
19. Howie BN, Donnelly P, Marchini J (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5:e1000529.
20. Johnson BA (2004) Role of the serotonergic system in the neurobiology of alcoholism. CNS Drugs 18:1105–1118.
21. Kendler KS, Chen X, Dick D, Maes H, Gillespie N, Neale MC, Riley B (2012) Recent advances in the genetic epidemiology and molecular genetics of substance use disorders. Nat Neurosci 15:181–189.
22. Kotte A, Faraone SV, Biederman J (2013) Association of genetic risk severity with ADHD clinical characteristics. Am J Med Genet B Neuropsychiatr Genet 162B:718–733.
23. LeMarquand D, Pihl RO, Benkelfat C (1994) Serotonin and alcohol intake, abuse, and dependence: findings of animal studies. Biol Psychiatry 36:395–421.
24. Li J, Ji L (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 95:221–227.
25. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, McCarroll SA, Visscher PM (2009) Finding the missing heritability of complex diseases. Nature 461:747–753.
26. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC (2001) Psychiatric aspects of impulsivity. Am J Psychiatry 158:1783–1793.
27. Monuteaux MC, Faraone SV, Hammerness P, Wilens TE, Fraire M, Biederman J (2008) The familial association between cigarette smoking and ADHD: a study of clinically referred girls with and without ADHD, and their families. Nicotine Tob Res 10:1549–1558.
28. Müller U, Asherson P, Banaschewski T, Buitelaar J, Ebstein R, Eisenberg J, Gill M, Manor I, Miranda A, Oades R (2011) The impact of study design and diagnostic approach in a large multi-centre ADHD study. Part 1: ADHD symptom patterns. BMC Psychiatry 11:54.
29. Neale BM, Lasky-Su J, Anney R, Franke B, Zhou K, Maller JB, Vasquez AA, Asherson P, Chen W, Banaschewski T (2008) Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147:1337–1344.
30. Nikolas MA, Burt SA (2010) Genetic and environmental influences on ADHD symptom dimensions of inattention and hyperactivity: a meta-analysis. J Abnorm Psychol 119:1–17.
31. Norton EC, Bieler GS, Ennett ST, Zarkin GA (1996) Analysis of prevention program effectiveness with clustered data using generalized estimating equations. J Consult Clin Psychol 64:919–926.
32. Oades RD (2010) 5-the role of serotonin in attention-deficit hyperactivity disorder (ADHD). Handb Behav Neurosci 21:565–584.
33. Olausson P, Engel JA, Soderpalm B (2002) Involvement of serotonin in nicotine dependence: processes relevant to positive and negative regulation of drug intake. Pharmacol Biochem Behav 71:757–771.
34. Otten R, Barker ED, Huizink AC, Engels RCME (2012) The interplay between parental monitoring and the dopamine D4 receptor gene in adolescent cannabis use. PLoS ONE 7:e49432.
35. Pauli-Pott U, Dalir S, Mingebach T, Roller A, Becker K (2013) Do different ADHD-related etiological risks involve specific neuropsychological pathways? An analysis of mediation processes by inhibitory control and delay aversion. J Child Psychol Psychiatry 54:800–809.
36. Plomin R, Haworth CM, Davis OS (2009) Common disorders are quantitative traits. Nat Rev Genet 10:872–878.
37. Rivero O, Sich S, Popp S, Schmitt A, Franke B, Lesch KP (2013) Impact of the ADHD-susceptibility gene CDH13 on development and function of brain networks. Eur Neuropsychopharmacol 23:492–507.
38. Rommelse NNJ, Oosterlaan J, Buitelaar J, Faraone SV, Sergeant JA (2007) Time reproduction in children with ADHD and their nonaffected siblings. J Am Acad Child Adolesc Psychiatry 46:582–590.
39. Scassellati C, Bonvicini C, Faraone SV, Gennarelli M (2012) Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses. J Am Acad Child Adolesc Psychiatry 51:1003–1019, e1020.
40. Schellekens AF, Franke B, Ellenbroek B, Cools A, de Jong CA, Buitelaar JK, Verkes RJ (2013) COMT Val158Met modulates the effect of childhood adverse experiences on the risk of alcohol dependence. Addict Biol 18:344–356.
41. Sofuoglu M, Sewell RA (2009) Norepinephrine and stimulant addiction. Addict Biol 14:119–129.
42. Stouffer SA, Suchman EA, DeVinney LC, Star SA, Williams Jr RM (1949) Studies in social psychology in World War II: The American soldier: adjustment during army life, Vol. 1. Princeton, NJ, Princeton University Press.
43. Treutlein J, Cichon S, Ridinger M, Wodarz N, Soyka M, Zill P, Maier W, Moessner R, Gaebel W, Dahmen N, Fehr C, Scherbaum N, Steffens M, Ludwig KU, Frank J, Wichmann HE, Schreiber S, Dragano N, Sommer WH, Leonardi-Essmann F, Lourdusamy A, Gebicke-Haerter P, Wienker TF, Sullivan PF, Nothen MM, Kiefer F, Spanagel R, Mann K, Rietschel M (2009) Genome-wide association study of alcohol dependence. Arch Gen Psychiatry 66:773–784.
44. Uhl GR, Drgon T, Liu QR, Johnson C, Walther D, Komiyama T, Harano M, Sekine Y, Inada T, Ozaki N, Iyo M, Iwata N, Yamada M, Sora I, Chen CK, Liu HC, Ujike H, Lin SK (2008) Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch Gen Psychiatry 65:345–355.
45. van de Glind G, Konstenius M, Koeter MW, van Emmerik-van Oortmerssen K, Carpentier PJ, Kaye S, Degenhardt L, Skutle A, Franck J, Bu ET, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitany-Foveny M, Fatseas M, Auriacombe M, Schillinger A, Moller M, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Schoevers RA, Wallhed S, Barta C, Alleman P, Levin FR, van den Brink W (2014) Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug Alcohol Depend 134:158–166.
46. van der Zwaluw CS, Engels RC, Vermulst AA, Franke B, Buitelaar J, Verkes RJ, Scholte RH (2010) Interaction between dopamine D2 receptor genotype and parental rule-setting in adolescent alcohol use: evidence for a gene-parenting interaction. Mol Psychiatry 15:727–735.
47. von Rhein D, Mennes M, van Ewijk H, Groenman AP, Zwiers MP, Oosterlaan J, Heslenfeld D, Franke B, Hoekstra PJ, Faraone SV, Hartman C, Buitelaar J (2014) The NeuroIMAGE study: a prospective phenotypic, cognitive, genetic and MRI study in children with attention-deficit/hyperactivity disorder. Design and descriptives. Eur Child Adolesc Psychiatry [Epud ahead of print].
48. Verbeeck W, Tuinier S, Bekkering GE (2009) Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review. Adv Ther 26:170–184.
49. Vink JM, Posthuma D, Neale MC, Slagboom PE, Boomsma DI (2006) Genome-wide linkage scan to identify loci for age at first cigarette in Dutch sibling pairs. Behav Genet 36:100–111.
50. Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F (2009) Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56 (Suppl. 1):3–8.
51. Weinshenker D, Schroeder JP (2007) There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32:1433–1451.